{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:13:39Z","timestamp":1778620419390,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T00:00:00Z","timestamp":1386633600000},"content-version":"vor","delay-in-days":2079,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Oncology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/s1470-2045(08)70076-7","type":"journal-article","created":{"date-parts":[[2008,3,19]],"date-time":"2008-03-19T01:51:06Z","timestamp":1205891466000},"page":"342-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":232,"title":["Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study"],"prefix":"10.1016","volume":"9","author":[{"given":"Roy","family":"Vergis","sequence":"first","affiliation":[]},{"given":"Catherine M","family":"Corbishley","sequence":"additional","affiliation":[]},{"given":"Andrew R","family":"Norman","sequence":"additional","affiliation":[]},{"given":"Jaclyn","family":"Bartlett","sequence":"additional","affiliation":[]},{"given":"Sameer","family":"Jhavar","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Borre","sequence":"additional","affiliation":[]},{"given":"Sara","family":"Heeboll","sequence":"additional","affiliation":[]},{"given":"Alan","family":"Horwich","sequence":"additional","affiliation":[]},{"given":"Robert","family":"Huddart","sequence":"additional","affiliation":[]},{"given":"Vincent","family":"Khoo","sequence":"additional","affiliation":[]},{"given":"Ros","family":"Eeles","sequence":"additional","affiliation":[]},{"given":"Colin","family":"Cooper","sequence":"additional","affiliation":[]},{"given":"Matthew","family":"Sydes","sequence":"additional","affiliation":[]},{"given":"David","family":"Dearnaley","sequence":"additional","affiliation":[]},{"given":"Chris","family":"Parker","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1470-2045(08)70076-7_bib1","first-page":"106","article-title":"Cancer statistics 2006","volume":"56","author":"Jemal","year":"2006","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/S1470-2045(08)70076-7_bib2","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1001\/jama.293.17.2095","article-title":"20-year outcomes following conservative management of clinically localised prostate cancer","volume":"293","author":"Albertsen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/S1470-2045(08)70076-7_bib3","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/sj.bjc.6603411","article-title":"Long-term outcome among men with conservatively treated localised prostate cancer","volume":"95","author":"Cuzick","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/S1470-2045(08)70076-7_bib4","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jnci\/djj190","article-title":"Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy","volume":"98","author":"Stephenson","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S1470-2045(08)70076-7_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1053-4296(96)80031-2","article-title":"Hypoxia and radiation response in human tumours","volume":"6","author":"Hockel","year":"1996","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/S1470-2045(08)70076-7_bib6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/bjc.1955.55","article-title":"The histological structure of some human lung cancers and the possible implications for radiotherapy","volume":"9","author":"Thomlinson","year":"1955","journal-title":"Br J Cancer"},{"key":"10.1016\/S1470-2045(08)70076-7_bib7","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis","volume":"359","author":"Shweiki","year":"1992","journal-title":"Nature"},{"key":"10.1016\/S1470-2045(08)70076-7_bib8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","article-title":"Tumour hypoxia: definitions and current clinical, biologic, and molecular aspects","volume":"93","author":"Hockel","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S1470-2045(08)70076-7_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0167-8140(99)00102-4","article-title":"Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome","volume":"53","author":"Brizel","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/S1470-2045(08)70076-7_bib10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(05)70292-8","article-title":"Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial","volume":"6","author":"Overgaard","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/S1470-2045(08)70076-7_bib11","first-page":"4509","article-title":"Association between tumour hypoxia and malignant progression in advanced cancer of the uterine cervix","volume":"56","author":"Hockel","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/S1470-2045(08)70076-7_bib12","first-page":"941","article-title":"Tumour oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma","volume":"56","author":"Brizel","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/S1470-2045(08)70076-7_bib13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","article-title":"Hypoxia in cancer: significance and impact on clinical outcome","volume":"26","author":"Vaupel","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/S1470-2045(08)70076-7_bib14","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/S1470-2045(08)70076-7_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-8140(97)00220-X","article-title":"A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85","volume":"46","author":"Overgaard","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/S1470-2045(08)70076-7_bib16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/28867","article-title":"Role of HIF-1 alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis","volume":"394","author":"Carmeliet","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S1470-2045(08)70076-7_bib17","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0360-3016(02)02848-1","article-title":"Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer","volume":"53","author":"Koukourakis","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S1470-2045(08)70076-7_bib18","first-page":"2911","article-title":"Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer","volume":"61","author":"Aebersold","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/S1470-2045(08)70076-7_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jnci\/89.2.139","article-title":"Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma","volume":"89","author":"Gasparini","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S1470-2045(08)70076-7_bib20","first-page":"2803","article-title":"Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer","volume":"6","author":"Cascinu","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S1470-2045(08)70076-7_bib21","first-page":"572","article-title":"Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis","volume":"6","author":"Kaya","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S1470-2045(08)70076-7_bib22","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1096\/fasebj.7.15.8262332","article-title":"Osteopontin: a protein with diverse functions","volume":"7","author":"Denhardt","year":"1993","journal-title":"Faseb J"},{"key":"10.1016\/S1470-2045(08)70076-7_bib23","doi-asserted-by":"crossref","first-page":"20794","DOI":"10.1074\/jbc.M311131200","article-title":"Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription","volume":"279","author":"El-Tanani","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/S1470-2045(08)70076-7_bib24","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.ijrobp.2006.07.1376","article-title":"Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels","volume":"66","author":"Bache","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S1470-2045(08)70076-7_bib25","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0360-3016(03)01621-3","article-title":"Polarographic electrode study of tumour oxygenation in clinically localised prostate cancer","volume":"58","author":"Parker","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S1470-2045(08)70076-7_bib26","first-page":"5830","article-title":"Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases","volume":"59","author":"Zhong","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/S1470-2045(08)70076-7_bib27","first-page":"1797","article-title":"Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma","volume":"24","author":"Strohmeyer","year":"2004","journal-title":"Anticancer Res"},{"key":"10.1016\/S1470-2045(08)70076-7_bib28","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1002\/ijc.21619","article-title":"Prognostic significance of osteopontin expression in human prostate cancer","volume":"118","author":"Forootan","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/S1470-2045(08)70076-7_bib29","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0090-4295(02)01858-7","article-title":"Hypoxic prostate\/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings","volume":"60","author":"Movsas","year":"2002","journal-title":"Urology"},{"key":"10.1016\/S1470-2045(08)70076-7_bib30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijrobp.2006.08.077","article-title":"Expression of vascular endothelial growth factor (VEGF) in locally invasive prostate cancer is prognostic for radiotherapy outcome","volume":"67","author":"Green","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S1470-2045(08)70076-7_bib31","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/j.1464-410X.2007.06734.x","article-title":"The expression of vascular endothelial growth factor is associated with the risk of cancer progression after radical prostatectomy","volume":"99","author":"Peyromaure","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/S1470-2045(08)70076-7_bib32","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/sj.bjc.6602301","article-title":"Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects","volume":"92","author":"Dearnaley","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/S1470-2045(08)70076-7_bib33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(07)70143-2","article-title":"Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial","volume":"8","author":"Dearnaley","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/S1470-2045(08)70076-7_bib34","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/sj.bjc.6602726","article-title":"Construction of tissue microarrays from prostate needle biopsy specimens","volume":"93","author":"Jhavar","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/S1470-2045(08)70076-7_bib35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000049777","article-title":"High-throughput microarray technologies: from genomics to clinics","volume":"40","author":"Bubendorf","year":"2001","journal-title":"Eur Urol"},{"key":"10.1016\/S1470-2045(08)70076-7_bib36","first-page":"1830","article-title":"Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy","volume":"61","author":"Koukourakis","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/S1470-2045(08)70076-7_bib37","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/(SICI)1096-9896(1998110)186:3<313::AID-PATH188>3.0.CO;2-X","article-title":"Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1","volume":"186","author":"Turley","year":"1998","journal-title":"J Pathol"},{"key":"10.1016\/S1470-2045(08)70076-7_bib38","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1158\/1078-0432.CCR-1405-2","article-title":"Correlation of osteopontin protein expression and pathological stage across a wide variety of tumour histologies","volume":"10","author":"Coppola","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S1470-2045(08)70076-7_bib39","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0090-4295(00)01044-X","article-title":"Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer","volume":"57","author":"Cvetkovic","year":"2001","journal-title":"Urology"},{"key":"10.1016\/S1470-2045(08)70076-7_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0360-3016(03)00439-5","article-title":"Evaluation of the Houston biochemical relapse definition in men treated with prolonged neoadjuvant and adjuvant androgen ablation and assessment of follow-up lead-time bias","volume":"57","author":"Pickles","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S1470-2045(08)70076-7_bib41","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1200\/JCO.2004.09.142","article-title":"Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy","volume":"22","author":"Shariat","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(08)70076-7_bib42","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/09553000600567616","article-title":"Relationship between radiobiological hypoxia in a C3H mouse mammary carcinoma and osteopontin levels in mouse serum","volume":"81","author":"Lukacova","year":"2005","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/S1470-2045(08)70076-7_bib43","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/pros.20540","article-title":"Plasma osteopontin in comparison with bone markers as indicator of bone metastasis and survival outcome in patients with prostate cancer","volume":"67","author":"Ramankulov","year":"2007","journal-title":"Prostate"},{"key":"10.1016\/S1470-2045(08)70076-7_bib44","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0022-5347(01)62925-2","article-title":"CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy","volume":"160","author":"Bettencourt","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/S1470-2045(08)70076-7_bib45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.pcan.4500572","article-title":"Microvessel density in prostate carcinoma","volume":"5","author":"Bono","year":"2002","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/S1470-2045(08)70076-7_bib46","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0090-4295(99)00202-2","article-title":"Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma","volume":"54","author":"Gettman","year":"1999","journal-title":"Urology"},{"key":"10.1016\/S1470-2045(08)70076-7_bib47","first-page":"2135","article-title":"Androgen withdrawal inhibits tumour growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model","volume":"24","author":"Cheng","year":"2004","journal-title":"Anticancer Res"},{"key":"10.1016\/S1470-2045(08)70076-7_bib48","doi-asserted-by":"crossref","first-page":"6022","DOI":"10.1158\/0008-5472.CAN-07-0561","article-title":"Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation response","volume":"67","author":"Milosevic","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/S1470-2045(08)70076-7_bib49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S1470-2045(08)70076-7_bib50","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa060655","article-title":"Sorafenib in advanced clear-cell renal-cell carcinoma","volume":"356","author":"Escudier","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S1470-2045(08)70076-7_bib51","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1172\/JCI31399","article-title":"Improved prediction of prostate cancer recurrence through systems pathology","volume":"117","author":"Cordon-Cardo","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/S1470-2045(08)70076-7_bib52","doi-asserted-by":"crossref","first-page":"6992","DOI":"10.1200\/JCO.2005.01.2906","article-title":"Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy","volume":"23","author":"Zhou","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["The Lancet Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470204508700767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470204508700767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T05:57:09Z","timestamp":1761458229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470204508700767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S1470204508700767"],"URL":"https:\/\/doi.org\/10.1016\/s1470-2045(08)70076-7","relation":{},"ISSN":["1470-2045"],"issn-type":[{"value":"1470-2045","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1470-2045(08)70076-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S1470-2045(08)70081-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}